Session Details

PRL05 Pearls: Hair Disorders

Sat, Jul 18, 9:45 AM - 10:30 AM
Pearls NEW

DESCRIPTION

This session will demonstrate the need for trichoscopy, close clinical examination, and how to best build an algorithm for treatment of both scarring and non-scarring alopecias. Medical, procedural, and surgical techniques will be discussed.

LEARNING OBJECTIVES

1.

To demonstrate complicated alopecia presentations and how to use the clinical exam and trichoscopy to choose the most appropriate and currently available treatments.

2.

To demonstrate surgical techniques for common forms of alopecia including laser and scalp restoration that maximizes outcomes.

3.

To identify and differentiate how hair loss can manifest across the age timeline and in patients of all hair types.

SCHEDULE

9:45 AM

Introduction

Amy J. McMichael, MD, FAAD

9:50 AM

Updates in Non-Scarring Alopecia

10:05 AM

Updates in Cicatricial Alopecia

Kathie Pei Huang, MD, FAAD

10:20 AM

Procedural and Surgical Options for Alopecia

DIRECTOR

Amy J. McMichael, MD, FAAD

Amy J. McMichael, MD, FAAD

Wake Forest University School of Medicine

SPEAKER

Kathie Pei Huang, MD, FAAD

Kathie Pei Huang, MD, FAAD

DISCLOSURES

Kathie Pei Huang, MD, FAAD

AbbVie – Consultant (1099 relationship)(Fees); IQVIA Solutions Australia Pty Ltd – Other(Fees);

Amy J. McMichael, MD, FAAD

Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);